1. OP0293 Weighted gene co-expression network analysis of DMARD-NAÏVE early ra patients achieving sustained drug-free remission after initiating tocilizumab therapy. (15th June 2017) Authors: Teitsma, XM; Jacobs, JW; Mokry, M; Pethö-Schramm, A; Borm, ME; Laar, JM van; Bijlsma, JW; Lafeber, FP Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0218 Effect of tocilizumab in DMARD-NAÏVE early rheumatoid arthritis patients on health-related quality of life: results of the U-ACT-EARLY trial. (15th June 2017) Authors: Teitsma, XM; Jacobs, JW; Welsing, PM; Pethö-Schramm, A; Borm, ME; Laar, JM van; Lafeber, FP; Bijlsma, JW Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗